Product has patent protection through 2044 - - Expected to be listed in the U.S. Food and Drug Administration’s (FDA) Orange ...

Desmopressin is approved in various forms, but these do not meet the paediatric need for precise, titratable and small doses.

Eton Pharma gets US patent covering its ET-600 product candidate’s proprietary formulation of desmopressin oral solution: Deer Park, Illinois Monday, February 10, 2025, 11:00 Hr ...

Eton Pharmaceuticals (ETON) announced that the United States Patent and Trademark Office has granted the company U.S. Patent No. 12,214,010, ...

Leerink raised the firm’s price target on Axsome Therapeutics (AXSM) to $150 from $110 and keeps an Outperform rating on the shares. The ...

Stifel analysts have maintained a Buy rating and a $28.00 price target for Phathom Pharmaceuticals (NASDAQ:PHAT), focusing on the company's recent developments. Currently trading at $5.59, ...

The following is a letter that ASL Strategic Value Fund sent to the Board of Directors of Avadel Pharmaceuticals (NASDAQ:AVDL): Mr.

Q4 2024 Earnings Call Transcript February 7, 2025 Iterum Therapeutics plc beats earnings expectations. Reported EPS is $-0.12 ...

Appellate courts issued a variety of notable intellectual property (IP) cases in 2024, including cases touching on Orange Book ...

In the coming years, an unprecedented number of people will leave planet Earth—but it’s becoming increasingly clear that deep ...

No television network has a lineup of shows as impressive as HBO. Whether iconic crime series, historical epics, or superhero ...

Reacher Season 3 takes a bold new direction as Jack Reacher goes undercover for the first time, teaming up with the DEA to bring down a dangerous criminal organization.